Want to join the conversation?
$MYL 2Q15 Call: We are raising our 2015 adjusted diluted EPS guidance range to 4.15-4.35, an increase of 19% or 23% on a constant currency basis compared to our performance in 2014. Our guidance now excludes any contribution from Generic Copaxone and includes potential generic competition on EpiPen in the second half of the year.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!